Works matching DE "ECULIZUMAB"

Results: 817

Paroxysmal nocturnal haemoglobinuria in pregnancy–a systematic review with meta analysis.

Published in:

Annals of Hematology, 2025, v. 104, n. 4, p. 2517, doi. 10.1007/s00277-025-06353-7

By:

Manning, James E.;
Ciantar, Etienne;
Griffin, Morag;
Kelly, Richard J.

Publication type:

Article

C1 esterase inhibitor in pediatric cardiac surgery with cardiopulmonary bypass plays a vital role in activation of the complement system.

Published in:

Heart & Vessels, 2020, v. 35, n. 1, p. 46, doi. 10.1007/s00380-019-01466-2

By:

Miyamoto, Takashi;
Ozaki, Shinichi;
Inui, Akitoshi;
Tanaka, Yuki;
Yamada, Yoshiyuki;
Matsumoto, Naoki

Publication type:

Article

Free Communications.

Published in:: Transplant International, 2013, v. 26, p. 1, doi. 10.1111/tri.12247
Publication type:: Article

Lectures.

Published in:: Transplant International, 2013, v. 26, p. 3, doi. 10.1111/tri.12180
Publication type:: Article

PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer.

Published in:

NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00291-7

By:

Dillon, Kasia M.;
Bekele, Raie T.;
Sztupinszki, Zsofia;
Hanlon, Timothy;
Rafiei, Shahrzad;
Szallasi, Zoltan;
Choudhury, Atish D.;
Mouw, Kent W.

Publication type:

Article

Antiphospholipid antibody-associated choroidopathy.

Published in:

Eye (0950-222X), 2014, v. 28, n. 6, p. 773, doi. 10.1038/eye.2014.39

By:

Silva, R A;
Moshfeghi, D M

Publication type:

Article

LncRNA MIAT enhances systemic lupus erythematosus by upregulating CFHR5 expression via miR-222 degradation.

Published in:

Central European Journal of Immunology, 2021, v. 46, n. 1, p. 17, doi. 10.5114/ceji.2021.105242

By:

YALI ZHANG;
LIYI XIE;
WANHONG LU;
JING LV;
YAN LI;
YAOZHONG SHAO;
JIPING SUN

Publication type:

Article

Investigations of cellular immunity in juvenile idiopathic arthritis.

Published in:

Central European Journal of Immunology, 2019, v. 44, n. 1, p. 92, doi. 10.5114/ceji.2019.83615

By:

SUR, LUCIA MARIA;
SUR, GENEL;
SAMASCA, GABRIEL;
LUPAN, IULIA

Publication type:

Article

Eculizumab in Pediatric Kidney Disorders: A Review.

Published in:

Journal of Pediatric Nephrology, 2022, v. 10, n. 3, p. 103, doi. 10.22037/jpn.v10i3.38928

By:

Jamee, Mahnaz;
Farsi, Yeganeh;
Akhondi, Amir Hossein;
Kamali, Farnaz;
Hajialigol, Amir Hossein;
Mirzaee, Mahbubeh;
Mohkam, Masoumeh

Publication type:

Article

Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis.

Published in:

2019

By:

Andersen, Henning;
Mantegazza, Renato;
Wang, Jing Jing;
O'Brien, Fanny;
Patra, Kaushik;
Howard, James F.;
Howard, James F Jr;
REGAIN Study Group

Publication type:

corrected article

Eculizumab improves fatigue in refractory generalized myasthenia gravis.

Published in:

2019

By:

Andersen, Henning;
Mantegazza, Renato;
Wang, Jing Jing;
O'Brien, Fanny;
Patra, Kaushik;
Howard, James F.;
Howard, James F Jr;
REGAIN Study Group

Publication type:

journal article

Safety of anti-SARS-CoV-2 vaccine in adult patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab - multicenter report by the Polish Adult Leukemia Group.

Published in:

Acta Haematologica Polonica, 2022, v. 53, n. A, p. 43

By:

Drozd-Sokołowska, Joanna;
Piekarska, Agnieszka;
Budziszewska, Katarzyna;
Mensah-Glanowska, Patrycja;
Bołkun, Łukasz;
Kozińska, Justyna;
Kopińska, Anna;
Rybka, Justyna;
Mądry, Krzysztof;
Jędrzejewska, Beata;
Giebel, Sebastian;
Gil, Lidia;
Dwilewicz-Trojaczek, Jadwiga;
Basak, Grzegorz Władysław

Publication type:

Article

Allogeneic hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria in the era of complement inhibition.

Published in:

Acta Haematologica Polonica, 2021, v. 52, n. 4, p. 253, doi. 10.5603/AHP.2021.0049

By:

Markiewicz, Mirosław

Publication type:

Article

SARS‐CoV‐2 targeting by RNAi and host complement inhibition: A two‐pronged subterfuge for COVID‐19 treatment.

Published in:

Immunity, Inflammation & Disease, 2022, v. 10, n. 1, p. 22, doi. 10.1002/iid3.549

By:

Naqvi, Raza Ali;
Shukla, Deepak;
Naqvi, Afsar R.

Publication type:

Article

Antibody‐mediated rejection in xenotransplantation: Can it be prevented or reversed?

Published in:

Xenotransplantation, 2023, v. 30, n. 4, p. 1, doi. 10.1111/xen.12816

By:

Habibabady, Zahra;
McGrath, Gannon;
Kinoshita, Kohei;
Maenaka, Akihiro;
Ikechukwu, Ileka;
Elias, Gabriela F.;
Zaletel, Tjasa;
Rosales, Ivy;
Hara, Hidetaka;
Pierson, Richard N.;
Cooper, David K. C.

Publication type:

Article

Invited commentary.

Published in:: Xenotransplantation, 2022, v. 29, n. 1, p. 1, doi. 10.1111/xen.12735
Publication type:: Article

Complement blockade with eculizumab to treat acute symptomatic humoral rejection after heart transplantation.

Published in:

Xenotransplantation, 2022, v. 29, n. 1, p. 1, doi. 10.1111/xen.12726

By:

Yerly, Patrick;
Rotman, Samuel;
Regamey, Julien;
Aubert, Vincent;
Aur, Stefania;
Kirsch, Matthias;
Hullin, Roger;
Pascual, Manuel

Publication type:

Article

Upfront use of eculizumab to treat early acute antibody‐mediated rejection after kidney allotransplantation and relevance for xenotransplantation.

Published in:

Xenotransplantation, 2020, v. 27, n. 4, p. 1, doi. 10.1111/xen.12630

By:

Schwotzer, Nora;
Paganetti, Giulia;
Barchi, Matteo;
Perrottet, Nancy;
Aubert, Vincent;
Sadallah, Salima;
Rotman, Samuel;
Venetz, Jean‐Pierre;
Matter, Maurice;
Golshayan, Dela;
Pascual, Manuel

Publication type:

Article

Selective inhibition of cyclooxygenase‐2 protects porcine aortic endothelial cells from human antibody‐mediated complement‐dependent cytotoxicity.

Published in:

Xenotransplantation, 2019, v. 26, n. 6, p. N.PAG, doi. 10.1111/xen.12536

By:

Chen, Pengfei;
Zhao, Yanli;
Gao, Hanchao;
Huang, Jiabao;
Lu, Ying;
Song, Jinqi;
Lin, Lizhong;
Lin, Zejin;
Ou, Chunpei;
Sun, Huimin;
Li, Yajing;
Zeng, Changchun;
Cooper, David K. C.;
Zhan, Yongqiang;
Deng, Xuefeng;
Mou, Lisha

Publication type:

Article

Xenotransplantation literature update, March-April 2016.

Published in:

Xenotransplantation, 2016, v. 23, n. 3, p. 249, doi. 10.1111/xen.12241

By:

Burlak, Christopher

Publication type:

Article

Successful pharmacological intervention at different levels of the complement system in an in vitro complement fixation model for bullous pemphigoid.

Published in:

Experimental Dermatology, 2023, v. 32, n. 5, p. 632, doi. 10.1111/exd.14755

By:

Giang, Jenny;
van Doorn, Martijn B. A.;
Diercks, Gilles F. H.;
de Cordoba, Santiago Rodriguez;
van den Bosch, Thierry P. P.;
Schreurs, Marco W. J.;
Poppelaars, Felix;
Damman, Jeffrey

Publication type:

Article

Do hair follicles operate as primitive, multifocal kidney‐like excretory (mini‐) organs?

Published in:

Experimental Dermatology, 2020, v. 29, n. 3, p. 357, doi. 10.1111/exd.14076

By:

Carré, Jean‐Luc;
Suzuki, Takahiro;
Paus, Ralf

Publication type:

Article

Complement Factor H Modulates Splenic B Cell Development and Limits Autoantibody Production.

Published in:

Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01607

By:

Kiss, Máté G.;
Ozsvár-Kozma, Mária;
Porsch, Florentina;
Göderle, Laura;
Papac-Miličević, Nikolina;
Bartolini-Gritti, Barbara;
Tsiantoulas, Dimitrios;
Pickering, Matthew C.;
Binder, Christoph J.

Publication type:

Article

The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System.

Published in:

Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01590

By:

Eriksson, Oskar;
Mohlin, Camilla;
Nilsson, Bo;
Ekdahl, Kristina N.

Publication type:

Article

Corrigendum: Complement System Inhibition Modulates the Pro-Inflammatory Effects of a Snake Venom Metalloproteinase.

Published in:

2019

By:

Luchini, Lygia Samartin Gonçalves;
Pidde, Giselle;
Squaiella-Baptistão, Carla Cristina;
Tambourgi, Denise V.

Publication type:

Correction Notice

Complement Receptor Type 1 (CR1, CD35), the Inhibitor of BCR-Mediated Human B Cell Activation, Differentially Regulates TLR7, and TLR9 Induced Responses.

Published in:

Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01493

By:

Mácsik-Valent, Bernadett;
Nagy, Katinka;
Fazekas, László;
Erdei, Anna

Publication type:

Article

Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT.

Published in:

Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01157

By:

Risitano, Antonio M.;
Marotta, Serena;
Ricci, Patrizia;
Marano, Luana;
Frieri, Camilla;
Cacace, Fabiana;
Sica, Michela;
Kulasekararaj, Austin;
Calado, Rodrigo T.;
Scheinberg, Phillip;
Notaro, Rosario;
Peffault de Latour, Regis

Publication type:

Article

The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy.

Published in:

Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00504

By:

Rizk, Dana V.;
Maillard, Nicolas;
Julian, Bruce A.;
Knoppova, Barbora;
Green, Todd J.;
Novak, Jan;
Wyatt, Robert J.

Publication type:

Article

C5b-9 inhibitor (eculizumab) for antibody-mediated rejection in renal transplantation

Published in:

Indian Journal of Transplantation, 2011, v. 5, n. 1, p. 6, doi. 10.1016/S2212-0017(11)60120-2

By:

Hamer, Rizwan;
Krishnan, Nithya;
Lowe, David;
Briggs, David;
Zehnder, Daniel;
Higgins, Robert

Publication type:

Article

Closing remarks from the IIGANN2023 Tokyo symposium—40 years of study progress in IgA nephropathy.

Published in:

Nephrology, 2024, v. 29, p. 80, doi. 10.1111/nep.14344

By:

Monteiro, Renato C.

Publication type:

Article

Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation.

Published in:

2017

By:

Lanfranco, Luca;
Joly, Melanie;
Del Bello, Arnaud;
Esposito, Laure;
Cognard, Noelle;
Perrin, Peggy;
Moulin, Bruno;
Kamar, Nassim;
Caillard, Sophie

Publication type:

Case Study

Eculizumab for the Treatment of Severe Antibody-Mediated Rejection: A Case Report and Review of the Literature.

Published in:

2016

By:

Tran, Duy;
Boucher, Anne;
Collette, Suzon;
Payette, Alexis;
Royal, Virginie;
Senécal, Lynne

Publication type:

Case Study

Is eculizumab efficacious in Shigatoxin-associated hemolytic uremic syndrome? A narrative review of current evidence.

Published in:

2018

By:

Keenswijk, Werner;
Raes, Ann;
Vande Walle, Johan

Publication type:

journal article

Pathogenesis-adaptive polydopamine nanosystem for sequential therapy of ischemic stroke.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43070-z

By:

Wu, Di;
Zhou, Jing;
Zheng, Yanrong;
Zheng, Yuyi;
Zhang, Qi;
Zhou, Zhuchen;
Chen, Xiaojie;
Chen, Qi;
Ruan, Yeping;
Wang, Yi;
Chen, Zhong

Publication type:

Article

Pathogenesis-adaptive polydopamine nanosystem for sequential therapy of ischemic stroke.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43070-z

By:

Wu, Di;
Zhou, Jing;
Zheng, Yanrong;
Zheng, Yuyi;
Zhang, Qi;
Zhou, Zhuchen;
Chen, Xiaojie;
Chen, Qi;
Ruan, Yeping;
Wang, Yi;
Chen, Zhong

Publication type:

Article

Treatment of a patient with classical paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome, with complement inhibitor eculizumab: Case Report.

Published in:

2013

By:

Mandala, E.;
Lafaras, C.;
Goulis, I.;
Tsioni, K.;
Georgopoulou, V.;
Ilonidis, G.

Publication type:

Case Study

A complement component C1q-mediated mechanism of antibody-dependent enhancement of Ebola virus infection.

Published in:

PLoS Neglected Tropical Diseases, 2020, v. 14, n. 9, p. 1, doi. 10.1371/journal.pntd.0008602

By:

Furuyama, Wakako;
Nanbo, Asuka;
Maruyama, Junki;
Marzi, Andrea;
Takada, Ayato

Publication type:

Article

Correction: Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy.

Published in:

2023

By:

Gialeli, Chrysostomi;
Tuysuz, Emre Can;
Staaf, Johan;
Guleed, Safa;
Paciorek, Veronika;
Mörgelin, Matthias;
Papadakos, Konstantinos S.;
Blom, Anna M.

Publication type:

Correction Notice

Sushi domain-containing protein 4 binds to epithelial growth factor receptor and initiates autophagy in an EGFR phosphorylation independent manner.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02565-1

By:

Papadakos, Konstantinos S.;
Ekström, Alexander;
Slipek, Piotr;
Skourti, Eleni;
Reid, Steven;
Pietras, Kristian;
Blom, Anna M.

Publication type:

Article

Follow-up of children with infection-associated haemolytic uraemic syndrome 1979-1995: Would eculizumab have improved prognosis?

Published in:

2020

By:

Aldridge, Melanie;
Burke, John

Publication type:

journal article

Eculizumab in paediatric atypical haemolytic uraemic syndrome: Lessons learned from a single-centre experience in the United Arab Emirates.

Published in:

2019

By:

Kumar, Gurinder;
Al‐Masri, Omar;
Alismaili, Zubaida;
Tawfik, Eslam;
Al‐Ghabra, Mohammed K;
Ilyas, Sadia H;
Al‐Khasawneh, Eihab;
Al-Masri, Omar;
Al-Ghabra, Mohammed K;
Al-Khasawneh, Eihab

Publication type:

journal article

Ethical dilemmas about orphan drugs for orphan diseases.

Published in:

2014

By:

Isaacs, David

Publication type:

Editorial

Trasplante renal exitoso con protocolo de eculizumab, timoglobulina y belatacept en paciente altamente sensibilizada con síndrome hemolítico urémico atípico por mutación del factor H.

Published in:

Nefrologia, 2018, v. 38, n. 4, p. 433, doi. 10.1016/j.nefro.2017.09.013

By:

Nieto-Ríos, John Fredy;
Zuluaga-Quintero, Mónica;
Bello-Márquez, Diana Carolina;
Aristizabal-Alzate, Arbey;
Ocampo-Kohn, Catalina;
Serna-Higuita, Lina María;
Arias, Lina;
Zuluaga-Valencia, Gustavo

Publication type:

Article

Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome.

Published in:

Nefrologia, 2018, v. 38, n. 4, p. 448, doi. 10.1016/j.nefro.2017.10.001

By:

Oruc, Aysegul;
Aya, Yavuz;
Vuruskan, Berna Aytac;
Yildiz, Abdulmecit;
Aktas, Nimet;
Yavuz, Mahmut;
Gullulu, Mustafa;
Dilek, Kamil;
Ersoy, Alparslan

Publication type:

Article

Case report: C3 glomerulopathy advancing atypical hemolytic uremic syndrome.

Published in:

2018

By:

Catikkas, Muge;
Demir, Erol;
Ozluk, Yasemin;
Caliskan, Yasar;
Badur, Rabia Muberra;
Turkmen, Aydin

Publication type:

Case Study

Microangiopatía trombótica secundaria y eculizumab: una opción terapéutica razonable.

Published in:

Nefrologia, 2017, v. 37, n. 5, p. 478, doi. 10.1016/j.nefro.2017.01.006

By:

Román, Elena;
Mendizábal, Santiago;
Jarque, Isidro;
De La Rubia, Javier;
Sempere, Amparo;
Morales, Enrique;
Praga, Manuel;
Ávila, Ana;
Luis Górriz, José

Publication type:

Article

Eculizumab for the treatment of an atypical hemolytic uremic syndrome with mutations in complement factor I and C3.

Published in:

2016

By:

Ferreira, Emanuel;
Oliveira, Nuno;
Marques, Maria;
Francisco, Luís;
Santos, Ana;
Carreira, Armando;
Campos, Mário

Publication type:

Letter to the Editor

C3 Glomerulopathies. A new perspective on glomerular diseases.

Published in:

Nefrologia, 2013, v. 33, n. 2, p. 164, doi. 10.3265/Nefrologia.pre2012.Nov.11802

By:

Rabasco-Ruiz, Cristina;
Huerta-Arroyo, Ana;
Caro-Espada, Jara;
Gutiérrez-Martínez, Eduardo;
Praga-Terente, Manuel

Publication type:

Article

The quality of economic evaluations of ultraorphan drugs in Europe - a systematic review.

Published in:

Orphanet Journal of Rare Diseases, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13023-015-0305-y

By:

Schuller, Y.;
Hollak, C. E. M.;
Biegstraaten, M.

Publication type:

Article

P-MAPA, a Fungi-Derived Immunomodulatory Compound, Induces a Proinflammatory Response in a Human Whole Blood Model.

Published in:

Mediators of Inflammation, 2020, p. 1, doi. 10.1155/2020/8831389

By:

Gonçalves, Mariana Torrente;
Squaiella-Baptistão, Carla Cristina;
Pidde, Giselle;
Lopes, Priscila Hess;
da Silva Nunes, Iseu;
Tambourgi, Denise V.

Publication type:

Article